Biomarkers of copper status

a brief update

Linda J. Harvey, Harry J. McArdle

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The essentiality of copper (Cu) in humans is demonstrated by various clinical features associated with deficiency, such as anaemia, hypercholesterolaemia and bone malformations. Despite significant effort over several decades a sensitive and specific Cu status biomarker has yet to be identified. The present article updates a comprehensive review recently published by the authors which assesses the reliability and robustness of current biomarkers and outlines the on-going search for novel indicators of status(1). The essential features of this earlier review are reiterated whilst considering whether there are other approaches, not yet tested, which may provide valuable information in the quest for an appropriate measure of copper status. Current biomarkers include a range of cuproenzymes such as the acute phase protein caeruloplasmin and Cu-Zn-superoxide dismutase all of which are influenced by a range of other dietary and environmental factors. A recent development is the identification of the Cu chaperone, CCS as a potential biomarker; although its reliability has yet to be established. This appears to be the most promising potential biomarker, responding to both Cu deficiency and excess. The potential for identifying a 'suite' of biomarkers using high-throughput technologies such as transcriptomics and proteomics is only now being examined. A combination of these technologies in conjunction with a range of innovative metal detection techniques is essential if the search for robust copper biomarkers is to be successful.

Original languageEnglish
Pages (from-to)S10-S13
Number of pages4
JournalBritish Journal of Nutrition
Volume99
Issue numberSupplement 3
DOIs
Publication statusPublished - Jun 2008

Keywords

  • copper status
  • biomarkers
  • copper deficiency
  • copper excess
  • dietary copper
  • stable-isotope
  • deficiency
  • disease
  • absorption
  • men
  • women
  • iron
  • supplementation
  • cholesterol

Cite this

Biomarkers of copper status : a brief update. / Harvey, Linda J.; McArdle, Harry J.

In: British Journal of Nutrition, Vol. 99, No. Supplement 3, 06.2008, p. S10-S13.

Research output: Contribution to journalArticle

Harvey, Linda J. ; McArdle, Harry J. / Biomarkers of copper status : a brief update. In: British Journal of Nutrition. 2008 ; Vol. 99, No. Supplement 3. pp. S10-S13.
@article{199f9c62083b4ba7838def48546d1009,
title = "Biomarkers of copper status: a brief update",
abstract = "The essentiality of copper (Cu) in humans is demonstrated by various clinical features associated with deficiency, such as anaemia, hypercholesterolaemia and bone malformations. Despite significant effort over several decades a sensitive and specific Cu status biomarker has yet to be identified. The present article updates a comprehensive review recently published by the authors which assesses the reliability and robustness of current biomarkers and outlines the on-going search for novel indicators of status(1). The essential features of this earlier review are reiterated whilst considering whether there are other approaches, not yet tested, which may provide valuable information in the quest for an appropriate measure of copper status. Current biomarkers include a range of cuproenzymes such as the acute phase protein caeruloplasmin and Cu-Zn-superoxide dismutase all of which are influenced by a range of other dietary and environmental factors. A recent development is the identification of the Cu chaperone, CCS as a potential biomarker; although its reliability has yet to be established. This appears to be the most promising potential biomarker, responding to both Cu deficiency and excess. The potential for identifying a 'suite' of biomarkers using high-throughput technologies such as transcriptomics and proteomics is only now being examined. A combination of these technologies in conjunction with a range of innovative metal detection techniques is essential if the search for robust copper biomarkers is to be successful.",
keywords = "copper status, biomarkers, copper deficiency, copper excess, dietary copper, stable-isotope, deficiency, disease, absorption, men, women, iron, supplementation, cholesterol",
author = "Harvey, {Linda J.} and McArdle, {Harry J.}",
year = "2008",
month = "6",
doi = "10.1017/S0007114508006806",
language = "English",
volume = "99",
pages = "S10--S13",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge Univ. Press.",
number = "Supplement 3",

}

TY - JOUR

T1 - Biomarkers of copper status

T2 - a brief update

AU - Harvey, Linda J.

AU - McArdle, Harry J.

PY - 2008/6

Y1 - 2008/6

N2 - The essentiality of copper (Cu) in humans is demonstrated by various clinical features associated with deficiency, such as anaemia, hypercholesterolaemia and bone malformations. Despite significant effort over several decades a sensitive and specific Cu status biomarker has yet to be identified. The present article updates a comprehensive review recently published by the authors which assesses the reliability and robustness of current biomarkers and outlines the on-going search for novel indicators of status(1). The essential features of this earlier review are reiterated whilst considering whether there are other approaches, not yet tested, which may provide valuable information in the quest for an appropriate measure of copper status. Current biomarkers include a range of cuproenzymes such as the acute phase protein caeruloplasmin and Cu-Zn-superoxide dismutase all of which are influenced by a range of other dietary and environmental factors. A recent development is the identification of the Cu chaperone, CCS as a potential biomarker; although its reliability has yet to be established. This appears to be the most promising potential biomarker, responding to both Cu deficiency and excess. The potential for identifying a 'suite' of biomarkers using high-throughput technologies such as transcriptomics and proteomics is only now being examined. A combination of these technologies in conjunction with a range of innovative metal detection techniques is essential if the search for robust copper biomarkers is to be successful.

AB - The essentiality of copper (Cu) in humans is demonstrated by various clinical features associated with deficiency, such as anaemia, hypercholesterolaemia and bone malformations. Despite significant effort over several decades a sensitive and specific Cu status biomarker has yet to be identified. The present article updates a comprehensive review recently published by the authors which assesses the reliability and robustness of current biomarkers and outlines the on-going search for novel indicators of status(1). The essential features of this earlier review are reiterated whilst considering whether there are other approaches, not yet tested, which may provide valuable information in the quest for an appropriate measure of copper status. Current biomarkers include a range of cuproenzymes such as the acute phase protein caeruloplasmin and Cu-Zn-superoxide dismutase all of which are influenced by a range of other dietary and environmental factors. A recent development is the identification of the Cu chaperone, CCS as a potential biomarker; although its reliability has yet to be established. This appears to be the most promising potential biomarker, responding to both Cu deficiency and excess. The potential for identifying a 'suite' of biomarkers using high-throughput technologies such as transcriptomics and proteomics is only now being examined. A combination of these technologies in conjunction with a range of innovative metal detection techniques is essential if the search for robust copper biomarkers is to be successful.

KW - copper status

KW - biomarkers

KW - copper deficiency

KW - copper excess

KW - dietary copper

KW - stable-isotope

KW - deficiency

KW - disease

KW - absorption

KW - men

KW - women

KW - iron

KW - supplementation

KW - cholesterol

U2 - 10.1017/S0007114508006806

DO - 10.1017/S0007114508006806

M3 - Article

VL - 99

SP - S10-S13

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - Supplement 3

ER -